We found that elevated WNT (Wg in Drosophila) activity led to upregulation of canonical nuclear factor-kappa B (NF-κB) signalling in RasG12V tumours, which in turn led to emergent resistance to drugs such as the MEK inhibitor trametinib by elevating glucuronidation pathway activity. Here, MAP2K7 is linked to neoplasm.